Contains a large (by standards of field :-)) dataset of all antibodies tested in phase-2 or phase-3 clinical trials measured "criteria regarding the feasibility of their manufacture, stability in storage, and absence of off-target stickiness."
This could be a valuable dataset for benchmarking antibody algorithmic techniques.
http://www.pnas.org/content/114/5/944.full
Contains a large (by standards of field :-)) dataset of all antibodies tested in phase-2 or phase-3 clinical trials measured "criteria regarding the feasibility of their manufacture, stability in storage, and absence of off-target stickiness."
This could be a valuable dataset for benchmarking antibody algorithmic techniques.